About 20%. But that is because 2 withdrew without receiving the treatment at all, and ALL who received at least one treatment demonstrated antitumor response as seen in substantially increased levels of IL-12 expressed. Only two of those five had received the full treatment at that point and one of them had a major response. Those were very encouraging results, despite small sample pool.